CLINICAL_TRIALS
ClinicalTrials.gov record update
Expanded Access Program for Pirtobrutinib for Previously Treated B-Cell Cancers
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT05172700
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:27:02.161782+00:00
- Published At
- 2024-12-18T00:00:00+00:00
- Record Updated At
- 2024-12-18
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Leukemia, Lymphocytic, Chronic, B-Cell", "Lymphoma, Lymphocytic, Small", "Lymphoma, Mantle-Cell", "Waldenstrom Macroglobulinemia", "Ritcher\u0027s Transformation, Syndrome"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-12-18"- protocolSection.identificationModule.nctId
"NCT05172700"- protocolSection.identificationModule.officialTitle
"Expanded Access Program for Pirtobrutinib for Previously Treated B-Cell Cancers"- protocolSection.statusModule.overallStatus
"APPROVED_FOR_MARKETING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.